Loading…

The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report

IntroductionEnterocytozoon bieneusi (E. bieneusi) Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these can be extremely debilitating and...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular and infection microbiology 2022, Vol.12, p.1072463-1072463
Main Authors: Zhou, Lanlan, Guan, Zebing, Chen, Chaolun, Zhu, Qiuhua, Qiu, Shiqiu, Liu, Yanan, Li, Mingjie, Zeng, Wenbin, Wang, Hong, Gao, Yanmin, Yuan, Yuemei, Zhang, Hanling, Ruan, Guanqiao, Pan, Xueyi
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1072463
container_issue
container_start_page 1072463
container_title Frontiers in cellular and infection microbiology
container_volume 12
creator Zhou, Lanlan
Guan, Zebing
Chen, Chaolun
Zhu, Qiuhua
Qiu, Shiqiu
Liu, Yanan
Li, Mingjie
Zeng, Wenbin
Wang, Hong
Gao, Yanmin
Yuan, Yuemei
Zhang, Hanling
Ruan, Guanqiao
Pan, Xueyi
description IntroductionEnterocytozoon bieneusi (E. bieneusi) Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these can be extremely debilitating and carry a significant risk of death for immunocompromised patients. Often, microsporidia cannot be confirmed immediately by routine examination and culture. Effective and available treatment options are limited for infections caused by E. bieneusi in humans. Such cases are very rare in Chinese Mainland. Case presentationA 47-year-old male had recurrent, profuse watery diarrhea and abdominal discomfort for more than 7 months, with a fever for 5 days. Two years earlier, he received treatment with a modified BFM-90 protocol for acute B cell lymphoblastic leukemia and is currently in the final stages of maintenance therapy with oral methotrexate and mercaptopurine. The leukemia was assessed as still in remission two months ago. PET/CT showed massive peritoneal fluid accumulation and a high uptake area in the diffused peritoneum (SUVmax 12.57), suggesting tumor invasion or microbial infections. However, broad-spectrum antibacterial therapies were ineffective. Metagenomic sequencing of plasma and peritoneal fluid showed no suggestion of the existence of a tumor but instead showed a high sequence number of DNA and RNA of the Microsporidia. His albendazole treatment failed and subsequent treatment with nitazoxanide successfully resolved the infection. ConclusionThis case shows that we should consider the possibility of atypical pathogen infection in patients with hematologic malignancy who repeatedly develop unexplained diarrhea with wasting. mNGS can help rule out malignant neoplasms and diagnose infections. Our results suggest that nitazoxanide effectively treats E. bieneusi microsporidia infections.
doi_str_mv 10.3389/fcimb.2022.1072463
format report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2769994066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2769994066</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_27699940663</originalsourceid><addsrcrecordid>eNqVjMFOwzAQRC0kJCroD3DaI5cE1y5JzK1URRzKBfVeue5GXZR4Q9YWUIl_pyB-gLnM4c0bpa5nurS2cbdtoH5XGm1MOdO1mVf2TE2MsXeFcU1zoaYir_qUWpvG2Yn62hwQJIeAIm3uII3oU48xAbewiglHDp-Jj8wRdoQRsxA8UxhZBh5pTywk8E7pAJGSP_KHj7RHoAgeBp_o5-oXPxSL9foeFrD0gvCCJz1dqfPWd4LTv75UN4-rzfKpGEZ-yyhp25ME7DofkbNsTV055-a6quw_pt-gcFpC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2769994066</pqid></control><display><type>report</type><title>The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report</title><source>PubMed Central</source><creator>Zhou, Lanlan ; Guan, Zebing ; Chen, Chaolun ; Zhu, Qiuhua ; Qiu, Shiqiu ; Liu, Yanan ; Li, Mingjie ; Zeng, Wenbin ; Wang, Hong ; Gao, Yanmin ; Yuan, Yuemei ; Zhang, Hanling ; Ruan, Guanqiao ; Pan, Xueyi</creator><creatorcontrib>Zhou, Lanlan ; Guan, Zebing ; Chen, Chaolun ; Zhu, Qiuhua ; Qiu, Shiqiu ; Liu, Yanan ; Li, Mingjie ; Zeng, Wenbin ; Wang, Hong ; Gao, Yanmin ; Yuan, Yuemei ; Zhang, Hanling ; Ruan, Guanqiao ; Pan, Xueyi</creatorcontrib><description>IntroductionEnterocytozoon bieneusi (E. bieneusi) Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these can be extremely debilitating and carry a significant risk of death for immunocompromised patients. Often, microsporidia cannot be confirmed immediately by routine examination and culture. Effective and available treatment options are limited for infections caused by E. bieneusi in humans. Such cases are very rare in Chinese Mainland. Case presentationA 47-year-old male had recurrent, profuse watery diarrhea and abdominal discomfort for more than 7 months, with a fever for 5 days. Two years earlier, he received treatment with a modified BFM-90 protocol for acute B cell lymphoblastic leukemia and is currently in the final stages of maintenance therapy with oral methotrexate and mercaptopurine. The leukemia was assessed as still in remission two months ago. PET/CT showed massive peritoneal fluid accumulation and a high uptake area in the diffused peritoneum (SUVmax 12.57), suggesting tumor invasion or microbial infections. However, broad-spectrum antibacterial therapies were ineffective. Metagenomic sequencing of plasma and peritoneal fluid showed no suggestion of the existence of a tumor but instead showed a high sequence number of DNA and RNA of the Microsporidia. His albendazole treatment failed and subsequent treatment with nitazoxanide successfully resolved the infection. ConclusionThis case shows that we should consider the possibility of atypical pathogen infection in patients with hematologic malignancy who repeatedly develop unexplained diarrhea with wasting. mNGS can help rule out malignant neoplasms and diagnose infections. Our results suggest that nitazoxanide effectively treats E. bieneusi microsporidia infections.</description><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2022.1072463</identifier><language>eng</language><ispartof>Frontiers in cellular and infection microbiology, 2022, Vol.12, p.1072463-1072463</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Zhou, Lanlan</creatorcontrib><creatorcontrib>Guan, Zebing</creatorcontrib><creatorcontrib>Chen, Chaolun</creatorcontrib><creatorcontrib>Zhu, Qiuhua</creatorcontrib><creatorcontrib>Qiu, Shiqiu</creatorcontrib><creatorcontrib>Liu, Yanan</creatorcontrib><creatorcontrib>Li, Mingjie</creatorcontrib><creatorcontrib>Zeng, Wenbin</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><creatorcontrib>Gao, Yanmin</creatorcontrib><creatorcontrib>Yuan, Yuemei</creatorcontrib><creatorcontrib>Zhang, Hanling</creatorcontrib><creatorcontrib>Ruan, Guanqiao</creatorcontrib><creatorcontrib>Pan, Xueyi</creatorcontrib><title>The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report</title><title>Frontiers in cellular and infection microbiology</title><description>IntroductionEnterocytozoon bieneusi (E. bieneusi) Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these can be extremely debilitating and carry a significant risk of death for immunocompromised patients. Often, microsporidia cannot be confirmed immediately by routine examination and culture. Effective and available treatment options are limited for infections caused by E. bieneusi in humans. Such cases are very rare in Chinese Mainland. Case presentationA 47-year-old male had recurrent, profuse watery diarrhea and abdominal discomfort for more than 7 months, with a fever for 5 days. Two years earlier, he received treatment with a modified BFM-90 protocol for acute B cell lymphoblastic leukemia and is currently in the final stages of maintenance therapy with oral methotrexate and mercaptopurine. The leukemia was assessed as still in remission two months ago. PET/CT showed massive peritoneal fluid accumulation and a high uptake area in the diffused peritoneum (SUVmax 12.57), suggesting tumor invasion or microbial infections. However, broad-spectrum antibacterial therapies were ineffective. Metagenomic sequencing of plasma and peritoneal fluid showed no suggestion of the existence of a tumor but instead showed a high sequence number of DNA and RNA of the Microsporidia. His albendazole treatment failed and subsequent treatment with nitazoxanide successfully resolved the infection. ConclusionThis case shows that we should consider the possibility of atypical pathogen infection in patients with hematologic malignancy who repeatedly develop unexplained diarrhea with wasting. mNGS can help rule out malignant neoplasms and diagnose infections. Our results suggest that nitazoxanide effectively treats E. bieneusi microsporidia infections.</description><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><recordid>eNqVjMFOwzAQRC0kJCroD3DaI5cE1y5JzK1URRzKBfVeue5GXZR4Q9YWUIl_pyB-gLnM4c0bpa5nurS2cbdtoH5XGm1MOdO1mVf2TE2MsXeFcU1zoaYir_qUWpvG2Yn62hwQJIeAIm3uII3oU48xAbewiglHDp-Jj8wRdoQRsxA8UxhZBh5pTywk8E7pAJGSP_KHj7RHoAgeBp_o5-oXPxSL9foeFrD0gvCCJz1dqfPWd4LTv75UN4-rzfKpGEZ-yyhp25ME7DofkbNsTV055-a6quw_pt-gcFpC</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Zhou, Lanlan</creator><creator>Guan, Zebing</creator><creator>Chen, Chaolun</creator><creator>Zhu, Qiuhua</creator><creator>Qiu, Shiqiu</creator><creator>Liu, Yanan</creator><creator>Li, Mingjie</creator><creator>Zeng, Wenbin</creator><creator>Wang, Hong</creator><creator>Gao, Yanmin</creator><creator>Yuan, Yuemei</creator><creator>Zhang, Hanling</creator><creator>Ruan, Guanqiao</creator><creator>Pan, Xueyi</creator><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report</title><author>Zhou, Lanlan ; Guan, Zebing ; Chen, Chaolun ; Zhu, Qiuhua ; Qiu, Shiqiu ; Liu, Yanan ; Li, Mingjie ; Zeng, Wenbin ; Wang, Hong ; Gao, Yanmin ; Yuan, Yuemei ; Zhang, Hanling ; Ruan, Guanqiao ; Pan, Xueyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_27699940663</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Lanlan</creatorcontrib><creatorcontrib>Guan, Zebing</creatorcontrib><creatorcontrib>Chen, Chaolun</creatorcontrib><creatorcontrib>Zhu, Qiuhua</creatorcontrib><creatorcontrib>Qiu, Shiqiu</creatorcontrib><creatorcontrib>Liu, Yanan</creatorcontrib><creatorcontrib>Li, Mingjie</creatorcontrib><creatorcontrib>Zeng, Wenbin</creatorcontrib><creatorcontrib>Wang, Hong</creatorcontrib><creatorcontrib>Gao, Yanmin</creatorcontrib><creatorcontrib>Yuan, Yuemei</creatorcontrib><creatorcontrib>Zhang, Hanling</creatorcontrib><creatorcontrib>Ruan, Guanqiao</creatorcontrib><creatorcontrib>Pan, Xueyi</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Lanlan</au><au>Guan, Zebing</au><au>Chen, Chaolun</au><au>Zhu, Qiuhua</au><au>Qiu, Shiqiu</au><au>Liu, Yanan</au><au>Li, Mingjie</au><au>Zeng, Wenbin</au><au>Wang, Hong</au><au>Gao, Yanmin</au><au>Yuan, Yuemei</au><au>Zhang, Hanling</au><au>Ruan, Guanqiao</au><au>Pan, Xueyi</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>12</volume><spage>1072463</spage><epage>1072463</epage><pages>1072463-1072463</pages><eissn>2235-2988</eissn><abstract>IntroductionEnterocytozoon bieneusi (E. bieneusi) Microsporidia can cause opportunistic infections in immunocompromised patients and is also an emerging disease in these individuals. Its clinical manifestations are chronic diarrhea and severe wasting syndrome, these can be extremely debilitating and carry a significant risk of death for immunocompromised patients. Often, microsporidia cannot be confirmed immediately by routine examination and culture. Effective and available treatment options are limited for infections caused by E. bieneusi in humans. Such cases are very rare in Chinese Mainland. Case presentationA 47-year-old male had recurrent, profuse watery diarrhea and abdominal discomfort for more than 7 months, with a fever for 5 days. Two years earlier, he received treatment with a modified BFM-90 protocol for acute B cell lymphoblastic leukemia and is currently in the final stages of maintenance therapy with oral methotrexate and mercaptopurine. The leukemia was assessed as still in remission two months ago. PET/CT showed massive peritoneal fluid accumulation and a high uptake area in the diffused peritoneum (SUVmax 12.57), suggesting tumor invasion or microbial infections. However, broad-spectrum antibacterial therapies were ineffective. Metagenomic sequencing of plasma and peritoneal fluid showed no suggestion of the existence of a tumor but instead showed a high sequence number of DNA and RNA of the Microsporidia. His albendazole treatment failed and subsequent treatment with nitazoxanide successfully resolved the infection. ConclusionThis case shows that we should consider the possibility of atypical pathogen infection in patients with hematologic malignancy who repeatedly develop unexplained diarrhea with wasting. mNGS can help rule out malignant neoplasms and diagnose infections. Our results suggest that nitazoxanide effectively treats E. bieneusi microsporidia infections.</abstract><doi>10.3389/fcimb.2022.1072463</doi></addata></record>
fulltext fulltext
identifier EISSN: 2235-2988
ispartof Frontiers in cellular and infection microbiology, 2022, Vol.12, p.1072463-1072463
issn 2235-2988
language eng
recordid cdi_proquest_miscellaneous_2769994066
source PubMed Central
title The successful treatment of Enterocytozoon bieneusi Microsporidiosis with nitazoxanide in a patient with B-ALL: A Case Report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A15%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=The%20successful%20treatment%20of%20Enterocytozoon%20bieneusi%20Microsporidiosis%20with%20nitazoxanide%20in%20a%20patient%20with%20B-ALL:%20A%20Case%20Report&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Zhou,%20Lanlan&rft.date=2022-01-01&rft.volume=12&rft.spage=1072463&rft.epage=1072463&rft.pages=1072463-1072463&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2022.1072463&rft_dat=%3Cproquest%3E2769994066%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_27699940663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2769994066&rft_id=info:pmid/&rfr_iscdi=true